List view / Grid view
21 May 2015 | By Victoria White
The EMA has granted orphan drug designation for ISTH0036, a locked nucleic acid-modified antisense oligonucleotide, to treat advanced-stage glaucoma...
21 May 2015 | By Victoria White
Researchers have identified three genes that play a pivotal role in choroid plexus carcinoma, a discovery that could lead to more effective treatment...
20 May 2015 | By Victoria White
Zealand has advanced a multiple-dose version of ZP4207 into clinical development for the treatment of mild to moderate hypoglycaemia in diabetes patients...
20 May 2015 | By Victoria White
Ipsen signed an agreement to acquire OctreoPharm Sciences, a life sciences company focusing on the development of innovative radioactive labelled compounds...
19 May 2015 | By Victoria White
Dr Leenhouts is set to discuss the progress with Mucosis' intranasal respiratory syncytial virus (RSV) vaccine candidate, SynGEM, at MVADS 2015...
19 May 2015 | By Victoria White
BioNTech has signed an agreement with Genmab to jointly research, develop and commercialise multiple bispecific antibodies for cancer immunotherapy...
19 May 2015 | By Victoria White
Researchers have discovered a key cause of life threatening heart complications, conditions that frequently follow severe Streptococcus pneumoniae infection..
18 May 2015 | By Victoria White
Broad Institute of MIT and Harvard are to receive a $10 million gift from the Gerstner Family Foundation that will expand cancer research...
18 May 2015 | By Victoria White
Anavex revealed full preclinical anti-seizure data for its lead drug candidate, ANAVEX 2-73, at the Antiepileptic Drug Trials XIII Conference...
18 May 2015 | By Victoria White
Ablynx is set to collaborate with Genzyme to investigate Nanobodies against a target that plays an important role in multiple sclerosis (MS)...
15 May 2015 | By Victoria White
The BaP combination of a cholesterol-lowering drug, bezafibrate and a contraceptive steroid could be an effective treatment for a range of cancers.
15 May 2015 | By Victoria White
Eli Lilly and Company and Sanford-Burnham Medical Research Institute are to collaborate to discover and develop immunological therapies...
14 May 2015 | By Victoria White
Novogen has confirmed that drug candidate, Anisina, is an effective monotherapy against human melanoma in an animal model...
14 May 2015 | By Victoria White
Acucela has announced the publication of preclinical data related to the Company’s investigational drug candidate emixustat hydrochloride...
14 May 2015 | By Victoria White
Antibiotic Research UK has welcomed this latest report to come from Jim O’Neill's Review on Antimicrobial Resistance and has endorses its recommendations...
